Cell-Based Microarrays for Rapid CTL-Antigen Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying cytolytic T lymphocyte (CTL)-recognized antigens are lengthy, low throughput, and struggle to detect antigens generated by natural processing events in live antigen-presenting cells, limiting the sensitivity and specificity of antigen identification.
Innovation Solution
A method involving cell-based microarrays where recombinant antigen-presenting cells expressing different target polynucleotides are contacted with CTLs, and caspase activity is detected using fluorogenic substrates to identify antigen-specific interactions at the single-cell level, allowing for rapid and sensitive detection of CTL-antigen recognition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cDNA libraries are screened through multi-well plates using traditional methods, then antigen identification can be performed, but the process is lengthy and low throughput
Solution Approach 1:
The invention divides the antigen screening process into discrete spatial units by spotting individual cDNAs or peptide libraries at separate locations on a microarray surface. This segmentation allows parallel evaluation of multiple antigens simultaneously in a single assay, transforming the sequential multi-well plate process into a parallel microarray process, thereby dramatically increasing throughput and reducing time loss.
Solution Approach 2:
The invention creates a microarray copy of the cDNA library or peptide library on a solid surface, allowing repeated and parallel access to multiple antigen sequences. This copying enables simultaneous presentation of numerous antigens to CTLs in a single assay, eliminating the need to process each antigen separately in multi-well plates and thus resolving the throughput and time loss issues.
2Measurement precision
If hundreds of genes compete for expression in antigen presenting cells, then antigen presentation occurs, but rarely expressed antigens become difficult to identify
Solution Approach 1:
The invention segments the competition problem by separating individual cDNA sequences into distinct spatial locations on the microarray. Each spot contains a single cDNA or a small set of cDNAs, eliminating the competitive expression problem inherent in pooled cDNA libraries. This segmentation allows rare antigens to be detected without being outcompeted by more abundant genes, thereby improving detection sensitivity while maintaining manageable complexity through localized presentation.
Solution Approach 2:
The invention applies local quality by presenting individual antigens or small groups of antigens at specific localized positions on the microarray surface. This local presentation ensures that each antigen is evaluated independently without competition from other genes, allowing rare or low-abundance antigens to be detected with high precision. The localized approach maintains simplicity by restricting each location to a specific antigen set, avoiding the complexity of global competition in pooled libraries.
3Productivity
If current methods are used to assess CTL cytotoxicity, then antigen recognition can be detected, but throughput is low and hampers antigen identification
Solution Approach 1:
The invention merges multiple CTL cytotoxicity assays into a single microarray platform by simultaneously presenting multiple antigens on one surface. This combining allows parallel evaluation of numerous antigen-CTL interactions in one experiment, transforming the low-throughput sequential assessment into a high-throughput parallel process, thereby resolving the productivity and time loss contradictions.
Solution Approach 2:
The invention creates a microarray copy of multiple antigens that can be simultaneously interrogated by CTLs in a single assay. This copying enables high-throughput assessment of CTL cytotoxicity against numerous antigens parallelly, eliminating the time-consuming sequential testing required by traditional methods and thus resolving the throughput and time loss issues.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables highly specific and sensitive detection of CTL-antigen interactions, requiring minimal starting material and allowing for the identification of rare antigens, facilitating applications in disease diagnosis and vaccine development.
Implementation Method 1
detecting the presence of a fluorescent signal generated from a fluorogenic caspase substrate present in said recombinant APCs
Data Source
AI summary
The invention provides methods and compositions for rapid, sensitive, and highly specific detection of antigen-specific interactions between cytolytic T lymphocytes (CTLs) and antigen presenting cells (APCs). The invention also features compositions, including kits, for use in the methods of the invention.